{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:58:42Z","timestamp":1782889122238,"version":"3.54.5"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Med"],"abstract":"<jats:p>Barth Syndrome (BTHS) is a rare X-linked disease, characterized clinically by cardiomyopathy, skeletal myopathy, neutropenia, and growth retardation. BTHS is caused by mutations in the phospholipid acyltransferase tafazzin (Gene: TAFAZZIN, TAZ). Tafazzin catalyzes the final step in the remodeling of cardiolipin (CL), a glycerophospholipid located in the inner mitochondrial membrane. As the phospholipid composition strongly determines membrane properties, correct biosynthesis of CL and other membrane lipids is essential for mitochondrial function. Mitochondria provide 95% of the energy demand in the heart, particularly due to their role in fatty acid oxidation. Alterations in lipid homeostasis in BTHS have an impact on mitochondrial membrane proteins and thereby contribute to cardiomyopathy. We analyzed a transgenic TAFAZZIN-knockdown (TAZ-KD) BTHS mouse model and determined the distribution of 193 individual lipid species in TAZ-KD and WT hearts at 10 and 50\u00a0weeks of age, using electrospray ionization tandem mass spectrometry (ESI-MS\/MS). Our results revealed significant lipid composition differences between the TAZ-KD and WT groups, indicating genotype-dependent alterations in most analyzed lipid species. Significant changes in the myocardial lipidome were identified in both young animals without cardiomyopathy and older animals with heart failure. Notable alterations were found in phosphatidylcholine (PC), phosphatidylethanolamine (PE), lysophosphatidylethanolamine (LPE), lysophosphatidylcholine (LPC) and plasmalogen species. PC species with 2\u20134 double bonds were significantly increased, while polyunsaturated PC species showed a significant decrease in TAZ-KD mice. Furthermore, Linoleic acid (LA, 18:2) containing PC and PE species, as well as arachidonic acid (AA, 20:4) containing PE 38:4 species are increased in TAZ-KD. We found higher levels of AA containing LPE and PE-based plasmalogens (PE P-). Furthermore, we are the first to show significant changes in sphingomyelin (SM) and ceramide (Cer) lipid species Very long-chained SM species are accumulating in TAZ-KD hearts, whereas long-chained Cer and several hexosyl ceramides (HexCer) species accumulate only in 50-week-old TAZ-KD hearts These findings offer potential avenues for the diagnosis and treatment of BTHS, presenting new possibilities for therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fmmed.2024.1389456","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T04:35:40Z","timestamp":1714365340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy"],"prefix":"10.3389","volume":"4","author":[{"given":"Malte","family":"Hachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcntas","family":"G\u00fclcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjithkumar","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Bachhuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kohlhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Maack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"Erg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Karnati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","article-title":"Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction","volume":"15","author":"Abudiab","year":"2013","journal-title":"Eur. J. Heart Fail"},{"key":"B2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1074\/jbc.M110.171439","article-title":"Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome","volume":"286","author":"Acehan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1152\/physiol.00014.2009","article-title":"Phosphoinositide signaling: new tools and insights","volume":"24","author":"Balla","year":"2009","journal-title":"Physiol. (Bethesda)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-510x(83)90209-5","article-title":"An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes","volume":"62","author":"Barth","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajmg.a.20660","article-title":"X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update","author":"Barth","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1023\/a:1005568609936","article-title":"X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060)","volume":"22","author":"Barth","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1161\/CIRCRESAHA.118.310082","article-title":"Calcium signaling and reactive oxygen species in mitochondria","volume":"122","author":"Bertero","year":"2018","journal-title":"Circ. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1161\/CIRCULATIONAHA.121.053755","article-title":"Loss of mitochondrial Ca(2+) uniporter limits inotropic reserve and provides trigger and substrate for arrhythmias in Barth syndrome cardiomyopathy","volume":"144","author":"Bertero","year":"2021","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10545-012-9552-4","article-title":"Diagnosis of Barth syndrome using a novel LC-MS\/MS method for leukocyte cardiolipin analysis","volume":"36","author":"Bowron","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jimd.12449","article-title":"Interplay between cardiolipin and plasmalogens in Barth syndrome","volume":"45","author":"Bozelli","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"158677","DOI":"10.1016\/j.bbalip.2020.158677","article-title":"Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model","volume":"1865","author":"Bozelli","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"B14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbalip.2003.12.010","article-title":"Functions and biosynthesis of plasmalogens in health and disease","volume":"1636","author":"Brites","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e102738","DOI":"10.1371\/journal.pone.0102738","article-title":"Specific interaction with cardiolipin triggers functional activation of Dynamin-Related Protein 1","volume":"9","author":"Bustillo-Zabalbeitia","year":"2014","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mito.2021.07.003","article-title":"High-resolution mass spectrometric analysis of cardiolipin profiles in Barth syndrome","volume":"60","author":"Byeon","year":"2021","journal-title":"Mitochondrion"},{"key":"B17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jimd.12094","article-title":"Blunted fat oxidation upon submaximal exercise is partially compensated by enhanced glucose metabolism in children, adolescents, and young adults with Barth syndrome","volume":"42","author":"Cade","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s12350-019-01933-3","article-title":"Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome","volume":"28","author":"Cade","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"40131","DOI":"10.1074\/jbc.M112.399428","article-title":"Phosphatidylserine decarboxylase 1 (Psd1) promotes mitochondrial fusion by regulating the biophysical properties of the mitochondrial membrane and alternative topogenesis of mitochondrial genome maintenance protein 1 (Mgm1)","volume":"287","author":"Chan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jimd.12459","article-title":"Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy","volume":"45","author":"Chatfield","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1365-2958.2008.06216.x","article-title":"Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth","volume":"68","author":"Chen","year":"2008","journal-title":"Mol. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e17399","DOI":"10.15252\/emmm.202317399","article-title":"Metabolic switch from fatty acid oxidation to glycolysis in knock-in mouse model of Barth syndrome","volume":"15","author":"Chowdhury","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ncb2837","article-title":"Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells","volume":"15","author":"Chu","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2020.05.001","article-title":"Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy","volume":"144","author":"Cole","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"B102","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.2337\/db16-0114","article-title":"Impaired cardiolipin biosynthesis prevents hepatic steatosis and diet-induced obesity","volume":"65","author":"Cole","year":"2016","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/S0006-3495(03)75079-6","article-title":"An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics","volume":"84","author":"Cortassa","year":"2003","journal-title":"Biophys. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/cvr\/cvx014","article-title":"Barth syndrome cardiomyopathy","volume":"113","author":"Dudek","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.bbamem.2018.01.017","article-title":"Cardiolipin dynamics and binding to conserved residues in the mitochondrial ADP\/ATP carrier","volume":"1860","author":"Duncan","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"460849","DOI":"10.1016\/j.chroma.2020.460849","article-title":"Aging-related lipidomic changes in mouse serum, kidney, and heart by nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry","volume":"1618","author":"Eum","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1755-7682-4-14","article-title":"Serum lipoprotein levels in takotsubo cardiomyopathy vs. myocardial infarction","volume":"4","author":"Gaddam","year":"2011","journal-title":"Int. Arch. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E576","DOI":"10.1152\/ajpendo.00523.2006","article-title":"Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes","volume":"293","author":"Guo","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"16684","DOI":"10.1021\/bi051908a","article-title":"Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction","volume":"44","author":"Han","year":"2005","journal-title":"Biochemistry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1139\/O09-186","article-title":"Reduction in cholesterol synthesis in response to serum starvation in lymphoblasts of a patient with Barth syndrome","volume":"88","author":"Hauff","year":"2010","journal-title":"Biochem. Cell Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1021\/acs.analchem.8b05013","article-title":"Quantification of cholesterol and cholesteryl ester by direct flow injection high-resolution fourier Transform mass spectrometry utilizing species-specific response factors","volume":"91","author":"Horing","year":"2019","journal-title":"Anal. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ab.2009.01.032","article-title":"Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome","volume":"387","author":"Houtkooper","year":"2009","journal-title":"Anal. Biochem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tem.2017.03.005","article-title":"Sphingolipids and lipoproteins in health and metabolic disorders","volume":"28","author":"Iqbal","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajmg.c.31372","article-title":"Barth syndrome","author":"Jefferies","year":"2013","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e96203","DOI":"10.1172\/jci.insight.96203","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight"},{"key":"B41","doi-asserted-by":"publisher","first-page":"17589","DOI":"10.1074\/jbc.M111.330167","article-title":"Cardiolipin and mitochondrial phosphatidylethanolamine have overlapping functions in mitochondrial fusion in Saccharomyces cerevisiae","volume":"287","author":"Joshi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00246-015-1260-z","article-title":"Clinical characteristics and outcomes of cardiomyopathy in Barth syndrome: the UK experience","volume":"37","author":"Kang","year":"2016","journal-title":"Pediatr. Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bpj.2012.11.3808","article-title":"Integrating mitochondrial energetics, redox and ROS metabolic networks: a two-compartment model","volume":"104","author":"Kembro","year":"2013","journal-title":"Biophys. J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1194\/jlr.M034728","article-title":"Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome","volume":"54","author":"Kiebish","year":"2013","journal-title":"J. Lipid Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1021\/acs.biochem.8b00042","article-title":"Substantial decrease in plasmalogen in the heart associated with tafazzin deficiency","volume":"57","author":"Kimura","year":"2018","journal-title":"Biochemistry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e201900348","DOI":"10.26508\/lsa.201900348","article-title":"Plasmalogen loss caused by remodeling deficiency in mitochondria","volume":"2","author":"Kimura","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1161\/CIRCULATIONAHA.110.968057","article-title":"Adverse bioenergetic consequences of Na+-Ca2+ exchanger-mediated Ca2+ influx in cardiac myocytes","volume":"122","author":"Kohlhaas","year":"2010","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.12997\/jla.2020.9.1.23","article-title":"Sphingolipid mediators of myocardial pathology","volume":"9","author":"Kovilakath","year":"2020","journal-title":"J. Lipid Atheroscler."},{"key":"B49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00395-023-01017-x","article-title":"Activation of the integrated stress response rewires cardiac metabolism in Barth syndrome","volume":"118","author":"Kutschka","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s0092-8674(03)00422-7","article-title":"Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal","volume":"113","author":"Lauber","year":"2003","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.bbamem.2009.03.014","article-title":"The physicochemical properties of cardiolipin bilayers and cardiolipin-containing lipid membranes","volume":"1788","author":"Lewis","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/clinchem\/48.12.2217","article-title":"High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry","volume":"48","author":"Liebisch","year":"2002","journal-title":"Clin. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/s0022-2275(20)33398-8","article-title":"Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS\/MS)","volume":"40","author":"Liebisch","year":"1999","journal-title":"J. Lipid Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1194\/jlr.S120001025","article-title":"Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures","volume":"61","author":"Liebisch","year":"2020","journal-title":"J. Lipid Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbalip.2004.09.003","article-title":"High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm","volume":"1686","author":"Liebisch","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"B57","doi-asserted-by":"publisher","first-page":"10672","DOI":"10.1074\/jbc.M117.783068","article-title":"The phospholipase iPLA(2)\u03b3 is a major mediator releasing oxidized aliphatic chains from cardiolipin, integrating mitochondrial bioenergetics and signaling","volume":"292","author":"Liu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1089\/ars.2012.4845","article-title":"Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I","volume":"19","author":"Maranzana","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J. Lipid Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"R465","DOI":"10.1016\/s0960-9822(06)00237-5","article-title":"Barth syndrome may be due to an acyltransferase deficiency","volume":"7","author":"Neuwald","year":"1997","journal-title":"Curr. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yjmcc.2014.03.011","article-title":"Mitochondrial reactive oxygen species production and elimination","volume":"73","author":"Nickel","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1016\/j.jlr.2021.100111","article-title":"Fatty acyl availability modulates cardiolipin composition and alters mitochondrial function in HeLa cells","volume":"62","author":"Oemer","year":"2021","journal-title":"J. Lipid Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1016\/j.celrep.2020.02.115","article-title":"Phospholipid acyl chain diversity controls the tissue-specific assembly of mitochondrial cardiolipins","volume":"30","author":"Oemer","year":"2020","journal-title":"Cell Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jimd.12433","article-title":"The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells","volume":"45","author":"Oemer","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J. Lipid Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"52873","DOI":"10.1074\/jbc.M308366200","article-title":"Cardiolipin stabilizes respiratory chain supercomplexes","volume":"278","author":"Pfeiffer","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.bpj.2015.07.034","article-title":"Cardiolipin interactions with proteins","volume":"109","author":"Planas-Iglesias","year":"2015","journal-title":"Biophys. J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3389\/fphys.2018.01165","article-title":"Lipidomics reveals a tissue-specific fingerprint","volume":"9","author":"Pradas","year":"2018","journal-title":"Front. Physiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1750-1172-8-70","article-title":"Natural history of Barth syndrome: a national cohort study of 22 patients","volume":"8","author":"Rigaud","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1002\/ajmg.a.35609","article-title":"The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study","author":"Roberts","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"B72","doi-asserted-by":"publisher","first-page":"19847","DOI":"10.1038\/s41598-022-24231-4","article-title":"Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice","volume":"12","author":"Russo","year":"2022","journal-title":"Sci. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/biom10111471","article-title":"Biophysical and lipidomic biomarkers of cardiac remodeling post-myocardial infarction in humans","volume":"10","author":"Samouillan","year":"2020","journal-title":"Biomolecules"},{"key":"B74","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.tem.2016.07.005","article-title":"Sphingolipid de novo biosynthesis: a rheostat of cardiovascular homeostasis","volume":"27","author":"Sasset","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"B75","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nchembio.1064","article-title":"The physical state of lipid substrates provides transacylation specificity for tafazzin","volume":"8","author":"Schlame","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.jacc.2003.06.015","article-title":"Phospholipid abnormalities in children with Barth syndrome","volume":"42","author":"Schlame","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ana.10176","article-title":"Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome","volume":"51","author":"Schlame","year":"2002","journal-title":"Ann. Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.stem.2019.02.020","article-title":"The mitochondrial transacylase, tafazzin, regulates for AML stemness by modulating intracellular levels of phospholipids","volume":"24","author":"Seneviratne","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1542\/peds.2005-2667","article-title":"Cardiac and clinical phenotype in Barth syndrome","volume":"118","author":"Spencer","year":"2006","journal-title":"Pediatrics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"H2122","DOI":"10.1152\/ajpheart.00479.2010","article-title":"Impaired cardiac reserve and severely diminished skeletal muscle O\u2082 utilization mediate exercise intolerance in Barth syndrome","volume":"301","author":"Spencer","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbalip.2006.03.005","article-title":"Phospholipid homeostasis in phosphatidylserine synthase-2-deficient mice","volume":"1761","author":"Steenbergen","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1091\/mbc.E15-06-0330","article-title":"Cardiolipin's propensity for phase transition and its reorganization by dynamin-related protein 1 form a basis for mitochondrial membrane fission","volume":"26","author":"Stepanyants","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1074\/jbc.M112.434183","article-title":"Phosphatidylethanolamine deficiency in Mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology","volume":"288","author":"Tasseva","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jimd.12422","article-title":"Clinical presentation and natural history of Barth Syndrome: an overview","volume":"45","author":"Taylor","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/gim.2015.204","article-title":"New targets for monitoring and therapy in Barth syndrome","volume":"18","author":"Thompson","year":"2016","journal-title":"Genet. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/metabo10060254","article-title":"The cardiac lipidome in models of cardiovascular disease","volume":"10","author":"Tomczyk","year":"2020","journal-title":"Metabolites"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI97949","article-title":"Role of sphingolipids in senescence: implication in aging and age-related diseases","volume":"128","author":"Trayssac","year":"2018","journal-title":"J. Clin. Invest"},{"key":"B88","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1194\/jlr.M200217-JLR200","article-title":"Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment","volume":"44","author":"Valianpour","year":"2003","journal-title":"J. Lipid Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/bbrc.2000.3952","article-title":"Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome","volume":"279","author":"Vreken","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.chemphyslip.2011.06.008","article-title":"Plasmalogens the neglected regulatory and scavenging lipid species","volume":"164","author":"Wallner","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"B91","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nm.3545","article-title":"Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jgg.2019.11.009","article-title":"Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression","volume":"47","author":"Wang","year":"2020","journal-title":"J. Genet. Genomics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/hmg\/ddad041","article-title":"Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome","volume":"32","author":"Wang","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies","volume":"364","author":"Watkins","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"11235","DOI":"10.1073\/pnas.1900890116","article-title":"Assembly of the complexes of oxidative phosphorylation triggers the remodeling of cardiolipin","volume":"116","author":"Xu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B96","doi-asserted-by":"publisher","first-page":"39217","DOI":"10.1074\/jbc.M606100200","article-title":"The enzymatic function of tafazzin","volume":"281","author":"Xu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jasms.2004.07.009","article-title":"Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids","volume":"15","author":"Zemski Berry","year":"2004","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e008289","DOI":"10.1161\/CIRCHEARTFAILURE.121.008289","article-title":"Cardiolipin remodeling defects impair mitochondrial architecture and function in a murine model of Barth syndrome cardiomyopathy","volume":"14","author":"Zhu","year":"2021","journal-title":"Circ. Heart Fail"},{"key":"B99","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.123.065414","article-title":"Temporal effects of safflower oil diet-based linoleic acid supplementation on Barth syndrome cardiomyopathy","volume":"149","author":"Zhu","year":"2024","journal-title":"Circulation"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/ATVBAHA.122.318048","article-title":"Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential","volume":"42","author":"Zietzer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bbalip.2016.02.011","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction","volume":"1861","author":"Zlobine","year":"2016","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Frontiers in Molecular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2024.1389456\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T04:35:43Z","timestamp":1714365343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmmed.2024.1389456\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":102,"alternative-id":["10.3389\/fmmed.2024.1389456"],"URL":"https:\/\/doi.org\/10.3389\/fmmed.2024.1389456","relation":{},"ISSN":["2674-0095"],"issn-type":[{"value":"2674-0095","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"article-number":"1389456"}}